DETAILED NOTES ON K2 DIABLO SPICE SPRAY

talquetamab will enhance the amount or influence of ergotamine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Talquetamab brings about cytokine release syndrome (CRS) that may suppress activity of CYP enzymes, causing improved exposure of CYP substrates.omaveloxolone will minimize the level or outcome of ergotamine by